31 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

- D3.164 - Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years

Thumbnail

- D3.165 - Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis

Thumbnail

- D3.166 - The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids

Thumbnail

- D3.167 - Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods

Thumbnail

- D3.169 - Advantage of IgG reactivity testing for the analytical quantification of allergoids

Thumbnail

- D3.172 - Аllergen-specific immunotherapy in patients with allergic rhinitis

Thumbnail

- D3.173 - Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

Thumbnail

- D3.174 - Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens

Thumbnail

- D3.175 - Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model

Thumbnail

- D3.176 - The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma